Gyre Therapeutics, Inc. · NASDAQ:GYRE
Songjiang Ma reported a 6.33% stake in Gyre Therapeutics, Inc. (Schedule 13D/A)
Event May 4, 2026 · Filed May 7, 2026
Songjiang Ma reported a 6.33% stake in Gyre Therapeutics, Inc., 7,342,131 shares, with active intent on May 4, 2026. Filed May 7, 2026 (Schedule 13D/A).
- Stake
- 6.33%
- Shares
- 7,342,131
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Songjiang Ma | 6.33% | 7,342,131 |
| Yueying Zhu | 6.33% | 7,342,131 |